Pharma Equity (Denmark) Buy Hold or Sell Recommendation
| PEG Stock | 0.14 0.01 6.67% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Pharma Equity Group is 'Strong Sell'. The recommendation algorithm takes into account all of Pharma Equity's available fundamental, technical, and predictive indicators you will find on this site.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. In addition, we conduct extensive research on individual companies such as Pharma and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Pharma Equity Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Pharma |
Execute Pharma Equity Buy or Sell Advice
The Pharma recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Pharma Equity Group. Macroaxis does not own or have any residual interests in Pharma Equity Group or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Pharma Equity's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Pharma Equity Trading Alerts and Improvement Suggestions
| Pharma Equity Group generated a negative expected return over the last 90 days | |
| Pharma Equity Group has some characteristics of a very speculative penny stock | |
| Pharma Equity Group has high historical volatility and very poor performance |
Pharma Equity Returns Distribution Density
The distribution of Pharma Equity's historical returns is an attempt to chart the uncertainty of Pharma Equity's future price movements. The chart of the probability distribution of Pharma Equity daily returns describes the distribution of returns around its average expected value. We use Pharma Equity Group price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Pharma Equity returns is essential to provide solid investment advice for Pharma Equity.
| Mean Return | -0.77 | Value At Risk | -10.53 | Potential Upside | 6.67 | Standard Deviation | 4.84 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Pharma Equity historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Pharma Equity Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Pharma Equity or Pharma sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Pharma Equity's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Pharma stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.89 | |
β | Beta against Dow Jones | 0.83 | |
σ | Overall volatility | 4.76 | |
Ir | Information ratio | -0.19 |
Pharma Equity Volatility Alert
Pharma Equity Group exhibits very low volatility with skewness of -0.05 and kurtosis of 0.65. Pharma Equity Group is a potential penny stock. Although Pharma Equity may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Pharma Equity Group. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Pharma instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Pharma Equity Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Pharma . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 115316.0 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 0.15 | |||
| Day Typical Price | 0.14 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
Use Investing Ideas to Build Portfolios
In addition to having Pharma Equity in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Market ETFs Thematic Idea Now
Broad Market ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Market ETFs theme has 58 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Market ETFs Theme or any other thematic opportunities.
| View All Next | Launch |